Skip Navigation


JAC Advance Access originally published online on May 25, 2009
Journal of Antimicrobial Chemotherapy 2009 64(2):294-300; doi:10.1093/jac/dkp185
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
64/2/294    most recent
dkp185v2
dkp185v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wolter, D. J.
Right arrow Articles by Hanson, N. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolter, D. J.
Right arrow Articles by Hanson, N. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype

Daniel J. Wolter*, Jennifer A. Black, Philip D. Lister and Nancy D. Hanson

Center for Research in Anti-Infectives and Biotechnology, Creighton University School of Medicine, Omaha, NE 68178, USA

Received 8 February 2009; returned 8 March 2009; revised 21 April 2009; accepted 27 April 2009


* Corresponding author. Present address: Department of Pediatrics, University of Washington, Seattle, WA 98195, USA. Tel: +1-206-221-0592; E-mail: dwolter{at}u.washington.edu

Objectives: Although Pseudomonas aeruginosa from cystic fibrosis patients are well known for their antibiotic resistance, isolates that are highly susceptible to multiple drug classes have also been encountered. In this study, hypersusceptible P. aeruginosa isolates were analysed for changes in intrinsic resistance mechanisms to explain the observed phenotype.

Methods: P. aeruginosa strains PA30 and PA431 were isolated from the sputa of cystic fibrosis patients and susceptibilities were determined by agar dilution. Isolates were genetically unrelated by PFGE analysis. Expression of efflux pumps, porins, a chromosomal cephalosporinase and a gene, glmS, previously implicated in hypersusceptibility were evaluated by real-time RT-PCR, outer membrane protein analysis and β-lactamase hydrolysis assays.

Results: PA30 was hypersusceptible to β-lactams, fluoroquinolones and antimetabolites, with MICs at least 4-fold lower than those for the prototype strain PAO1, while PA431 was hypersusceptible to β-lactams and antimetabolites. Both isolates overproduced the porin OprF but showed down-regulation in the production of the carbapenem channel OprD despite carbapenem hypersusceptibility. PA30 had decreased expression of the mexABoprM pump involved with intrinsic antibiotic resistance but overexpressed the mexCDoprJ and mexEFoprN efflux systems normally associated with acquired resistance. PA431 showed down-regulation of oprM, the last gene in the mexABoprM operon, but overexpressed the mexXY pump. The ampC β-lactamase was weakly inducible in strain PA30, corresponding to cefoxitin hypersusceptibility.

Conclusions: The changes in expression of several intrinsic mechanisms in the hypersusceptible strains did not correlate with the observed phenotype. These data highlight the complex interactions of resistance mechanisms in P. aeruginosa and their roles in drug susceptibility.

Keywords: P. aeruginosa , efflux , oprD , oprF , ampC


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.